{"id":"https://openalex.org/W1543472555","doi":null,"title":"Application of FAST\u2122 fragment-based lead discovery and structure-guided design to discovery of small molecule inhibitors of BCR-ABL tyrosine kinase active against the T315I imatinib-resistant mutant","display_name":"Application of FAST\u2122 fragment-based lead discovery and structure-guided design to discovery of small molecule inhibitors of BCR-ABL tyrosine kinase active against the T315I imatinib-resistant mutant","publication_year":2006,"publication_date":"2006-04-15","ids":{"openalex":"https://openalex.org/W1543472555","mag":"1543472555"},"language":"en","primary_location":{"id":"mag:1543472555","doi":null,"is_oa":false,"landing_page_url":"https://cancerres.aacrjournals.org/content/66/8_Supplement/1139.2","pdf_url":null,"source":{"id":"https://openalex.org/S168522863","display_name":"Cancer Research","issn_l":"0008-5472","issn":["0008-5472","1538-7445"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320273","host_organization_name":"American Association for Cancer Research","host_organization_lineage":["https://openalex.org/P4310320273"],"host_organization_lineage_names":["American Association for Cancer Research"],"type":"journal"},"license":null,"license_id":null,"version":null,"is_accepted":false,"is_published":false,"raw_source_name":"Cancer Research","raw_type":null},"volume":null,"type":"article","indexed_in":[],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5068648875","display_name":"Stephen Kevin Burley","orcid":"https://orcid.org/0000-0002-2487-9713","observed_orcids":["https://orcid.org/0000-0002-2487-9713"]},"institutions":[],"countries":[],"is_corresponding":true,"raw_author_name":"S.K. Burley","raw_affiliation_strings":["SGX Pharmaceuticals, Inc., San Diego, CA"],"raw_orcid":"https://orcid.org/0000-0002-2487-9713","affiliations":[{"raw_affiliation_string":"SGX Pharmaceuticals, Inc., San Diego, CA","institution_ids":[]}]}],"institutions":[],"countries_distinct_count":0,"institutions_distinct_count":0,"corresponding_author_ids":["https://openalex.org/A5068648875"],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":2.5128,"has_fulltext":false,"cited_by_count":15,"citation_normalized_percentile":{"value":0.89380208,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":89,"max":93},"biblio":{"volume":"66","issue":null,"first_page":"1139","last_page":"1139"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11215","display_name":"Chronic Myeloid Leukemia Treatments","score":0.8521000146865845,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T11215","display_name":"Chronic Myeloid Leukemia Treatments","score":0.8521000146865845,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10211","display_name":"Computational Drug Discovery Methods","score":0.09889999777078629,"subfield":{"id":"https://openalex.org/subfields/1703","display_name":"Computational Theory and Mathematics"},"field":{"id":"https://openalex.org/fields/17","display_name":"Computer Science"},"domain":{"id":"https://openalex.org/domains/3","display_name":"Physical Sciences"}},{"id":"https://openalex.org/T11157","display_name":"Chronic Lymphocytic Leukemia Research","score":0.006399999838322401,"subfield":{"id":"https://openalex.org/subfields/2716","display_name":"Genetics (clinical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/bcr-abl-tyrosine-kinase","display_name":"BCR-ABL tyrosine kinase","score":0.9599999785423279},{"id":"https://openalex.org/keywords/t315i-mutation","display_name":"T315I mutation","score":0.8799999952316284},{"id":"https://openalex.org/keywords/imatinib-resistance","display_name":"imatinib resistance","score":0.996999979019165},{"id":"https://openalex.org/keywords/chronic-myeloid-leukemia","display_name":"chronic myeloid leukemia","score":0.9599999785423279},{"id":"https://openalex.org/keywords/fragment-based-drug-discovery","display_name":"fragment-based drug discovery","score":0.9169999957084656},{"id":"https://openalex.org/keywords/structure-based-drug-design","display_name":"structure-based drug design","score":0.8460000157356262},{"id":"https://openalex.org/keywords/small-molecule-kinase-inhibitors","display_name":"small-molecule kinase inhibitors","score":0.8149999976158142},{"id":"https://openalex.org/keywords/philadelphia-chromosome","display_name":"Philadelphia chromosome","score":0.7049999833106995},{"id":"https://openalex.org/keywords/bcr-abl-mutations","display_name":"BCR-ABL mutations","score":0.6790000200271606},{"id":"https://openalex.org/keywords/k562-cells","display_name":"K562 cells","score":0.8709999918937683},{"id":"https://openalex.org/keywords/ba-f3-cells","display_name":"Ba/F3 cells","score":0.9729999899864197}],"concepts":[{"id":"https://openalex.org/C2777583451","wikidata":"https://www.wikidata.org/wiki/Q177094","display_name":"Imatinib","level":3,"score":0.7028671503067017},{"id":"https://openalex.org/C2776960273","wikidata":"https://www.wikidata.org/wiki/Q729735","display_name":"Chronic myelogenous leukemia","level":3,"score":0.6919097900390625},{"id":"https://openalex.org/C42362537","wikidata":"https://www.wikidata.org/wiki/Q87099740","display_name":"Tyrosine kinase","level":3,"score":0.6495640277862549},{"id":"https://openalex.org/C143065580","wikidata":"https://www.wikidata.org/wiki/Q3285695","display_name":"Mutant","level":3,"score":0.6195200681686401},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.548214852809906},{"id":"https://openalex.org/C125418893","wikidata":"https://www.wikidata.org/wiki/Q587961","display_name":"ABL","level":4,"score":0.5210408568382263},{"id":"https://openalex.org/C3019892230","wikidata":"https://www.wikidata.org/wiki/Q177094","display_name":"Imatinib mesylate","level":4,"score":0.5011670589447021},{"id":"https://openalex.org/C2778904597","wikidata":"https://www.wikidata.org/wiki/Q1129111","display_name":"Philadelphia chromosome","level":4,"score":0.4884611666202545},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.43893739581108093},{"id":"https://openalex.org/C138626823","wikidata":"https://www.wikidata.org/wiki/Q916504","display_name":"Chromosomal translocation","level":3,"score":0.3218628764152527},{"id":"https://openalex.org/C2778461978","wikidata":"https://www.wikidata.org/wiki/Q29496","display_name":"Leukemia","level":2,"score":0.27509188652038574},{"id":"https://openalex.org/C62478195","wikidata":"https://www.wikidata.org/wiki/Q828130","display_name":"Signal transduction","level":2,"score":0.230142742395401},{"id":"https://openalex.org/C54355233","wikidata":"https://www.wikidata.org/wiki/Q7162","display_name":"Genetics","level":1,"score":0.16411951184272766},{"id":"https://openalex.org/C104317684","wikidata":"https://www.wikidata.org/wiki/Q7187","display_name":"Gene","level":2,"score":0.11230665445327759},{"id":"https://openalex.org/C2778729363","wikidata":"https://www.wikidata.org/wiki/Q11688946","display_name":"Myeloid leukemia","level":2,"score":0.06365856528282166}],"mesh":[],"locations_count":1,"locations":[{"id":"mag:1543472555","doi":null,"is_oa":false,"landing_page_url":"https://cancerres.aacrjournals.org/content/66/8_Supplement/1139.2","pdf_url":null,"source":{"id":"https://openalex.org/S168522863","display_name":"Cancer Research","issn_l":"0008-5472","issn":["0008-5472","1538-7445"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320273","host_organization_name":"American Association for Cancer Research","host_organization_lineage":["https://openalex.org/P4310320273"],"host_organization_lineage_names":["American Association for Cancer Research"],"type":"journal"},"license":null,"license_id":null,"version":null,"is_accepted":false,"is_published":false,"raw_source_name":"Cancer Research","raw_type":null}],"best_oa_location":null,"sustainable_development_goals":[{"score":0.9476000070571899,"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W2979960304","https://openalex.org/W2576568647","https://openalex.org/W2378015739","https://openalex.org/W954745799","https://openalex.org/W2136306408","https://openalex.org/W4393093940","https://openalex.org/W4396926226","https://openalex.org/W2076271269","https://openalex.org/W2015276781","https://openalex.org/W2589015506"],"abstract_inverted_index":{"4851":[0],"The":[2,27,58,93],"Philadelphia":[3],"chromosome":[4],"translocation":[5],"creates":[6],"a":[7,13,147],"BCR-ABL":[8,16,35,85,113,131,166,209,218,254],"fusion":[9],"gene":[10],"that":[11,34,76,183],"encodes":[12],"constitutively":[14],"active":[15,73],"tyrosine":[17,36],"kinase,":[18],"which":[19,69],"gives":[20],"rise":[21,71],"to":[22,55,64,72,79,160],"chronic":[23],"myelogenous":[24],"leukemia":[25],"(CML).":[26],"clinical":[28,91],"success":[29],"of":[30,60,98,105,110,121,141,164,201,214,251],"imatinib":[31,51],"(Gleevec)":[32],"demonstrated":[33],"kinase":[37],"inhibitors":[38,163,256],"can":[39],"provide":[40],"effective":[41],"treatment":[42],"for":[43,139],"CML.":[44],"However,":[45],"some":[46],"CML":[47,142],"patients":[48],"treated":[49],"with":[50,207],"develop":[52],"resistance":[53,61],"leading":[54],"disease":[56],"progression.":[57],"majority":[59,213],"is":[62],"due":[63],"point":[65],"mutations":[66],"in":[67,90,192,242,245],"BCR-ABL,":[68],"give":[70],"mutant":[74,95],"enzymes":[75],"are":[77],"insensitive":[78],"imatinib.":[80],"In":[81],"all,":[82],"\u223c30":[83],"imatinib-resistant":[84],"mutants":[86,125],"have":[87,145],"been":[88],"identified":[89],"isolates.":[92],"T315I":[94,130,189,255],"represents":[96],"\u223c20%":[97],"clinically":[99,123,216],"observed":[100],"mutations,":[101,219],"making":[102],"it":[103],"one":[104],"the":[106,122,168,211,215],"most":[107,170,194],"common":[108,171],"causes":[109],"resistance.":[111],"Second-generation":[112],"inhibitors,":[114],"including":[115,173,220],"AMN-107":[116],"and":[117,136,156,167,188,204,210,235,244,248],"BMS-354825,":[118],"inhibit":[119,184,199],"many":[120],"relevant":[124,217],"but":[126],"not":[127],"T315I.":[128,174],"Mutant":[129],"is,":[132],"therefore,":[133],"an":[134],"important":[135],"challenging":[137],"target":[138],"discovery":[140,153,177],"therapeutics.":[143],"We":[144],"applied":[146],"proprietary":[148],"X-ray":[149],"crystallographic":[150],"fragment-based":[151],"lead":[152,158,176,196],"platform":[154],"(FAST\u2122)":[155],"structure-guided":[157],"optimization":[159],"identify":[161],"potent":[162],"wild-type":[165,186],"four":[169],"mutants,":[172],"Our":[175],"efforts":[178],"yielded":[179],"five":[180],"chemical":[181],"series":[182,197],"both":[185],"(WT)":[187],"BCR-ABL.":[190],"Compounds":[191],"our":[193],"advanced":[195],"potently":[198],"proliferation":[200],"K562":[202],"cells":[203,206],"Ba/F3":[205],"WT":[208],"vast":[212],"M244V,":[221],"G250E,":[222],"Q252H,":[223],"Y253F,":[224],"Y253H,":[225],"E255K,":[226],"F311L,":[227],"T315I,":[228],"F317L,":[229],"M351T,":[230],"F359V,":[231],"V279I,":[232],"L387M,":[233],"H396P,":[234],"H396R":[236],"(see":[237],"below).":[238],"Further":[239],"details":[240],"describing":[241],"vitro":[243],"vivo":[246],"profiling":[247],"efficacy":[249],"testing":[250],"these":[252],"novel":[253],"will":[257],"be":[258],"presented.":[259]},"counts_by_year":[{"year":2013,"cited_by_count":1}],"updated_date":"2026-11-04T10:54:05.112534","created_date":"2016-06-24T00:00:00"}